EGCG significantly attenuated histopathologic changes (vitiligo) in the skin by reducing excessive inflammatory responses, especially the infiltration of CD8+ T cells, and by markedly inhibiting inflammatory mediators such as tumor necrosis factor‐alpha (TNF‐α) and IL‐6 levels [52]. The gene discussed is TNF; the disease is vitiligo.